BMY Bristol-Myers Squibb Company
BMY Bristol-Myers Squibb Company
Healthcare · Drug Manufacturers - General
Desk view
Market read
Scan convergence 1 scan as of 2026-10-16 1 bull converging
POC $57.21 · VWAP $56.69 · +5.4% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
BMY Price Structure
Loading timeframes…
Peers
Every watchlist BMY belongs to, members best 30-day change first — BMY highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech
Against street estimates
How BMY's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
News (last pull)
Headlines about BMY from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 29 days ago · Sep 18
- Bristol Myers Squibb Posts Strong Q2 2026 Results ...
- Bristol Myers Squibb (BMY) Earnings Date and Reports 2026
- Bristol Myers Squibb Q2 2026 Results Boost Guidance
- Bristol-Myers Squibb Company (BMY) Share Price Live | US Stock Data & Chart
- Bristol-Myers Squibb Company (BMY) Live Share Price, Invest From India
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
BMY research tape
33 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.